Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
Volume 7 – Number 3
A Safe, Effective and Affordable HIV Vaccine – An Urgent Global Need
Enfuvirtide, the First Fusion Inhibitor to Treat HIV Infection
First-line Antiretroviral Therapy in Africa – How Evidence-based are our Recommendations?
High-Risk Dysmetabolism Disorders Associated with HAART Treated Drugs, in a Clinical and a Socio-Economic Perspective
Antiretroviral Therapy in Chronic Liver Disease: Focus on HIV/HCV Coinfection – Statements of the First Italian Consensus Workshop
Proinflammatory Cytokines in HIV Disease – A Review and Rationale for New Therapeutic Approaches
British HIV Guidelines for the Management of Hepatitis B and C in HIV-Coinfected Patients
HIV Chemotherapy Revisited
Discontinuation of Aplaviroc Trials due to Hepatotoxicity
Safety-related Changes to the Nevirapine (Viramune®) Label